Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Tp 3654
2. Tp3654
3. Vasoactive Intestinal Peptide-aba-gly-gly-ala-gly
4. Vip-aba-gly-gly-(d)-ala-gly
5. Vip-aminobutyric Acid-glycyl-glycyl-(d)-alanyl-glycine
1. Tp-3654
2. 1361951-15-6
3. Tp3654
4. Sgi-9481
5. Eob0n7boy4
6. 2-(4-((3-(3-(trifluoromethyl)phenyl)imidazo(1,2-b)pyridazin-6-yl)amino)cyclohexyl)propan-2-ol
7. 4-((3-(3-(trifluoromethyl)phenyl)imidazo(1,2-b)pyridazin-6-yl)amino) -trans-cyclohexyl)propan-2-ol
8. 2-[4-[[3-[3-(trifluoromethyl)phenyl]imidazo[1,2-b]pyridazin-6-yl]amino]cyclohexyl]propan-2-ol
9. Unii-eob0n7boy4
10. Schembl102560
11. Chembl3975308
12. Schembl19986953
13. Schembl20794171
14. Schembl22421478
15. Bdbm242374
16. Bcp30070
17. Ex-a1828
18. Nsc805149
19. Akos032960444
20. Cs-6293
21. Nsc-805149
22. Sb17245
23. Tp 3654
24. Ncgc00511354-02
25. Tp3654; Tp 3654
26. Ac-36196
27. Bs-15262
28. Hy-101126
29. S6774
30. C72454
31. A857573
32. Us9416132, 8-31
Molecular Weight | 418.5 g/mol |
---|---|
Molecular Formula | C22H25F3N4O |
XLogP3 | 4.6 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 7 |
Rotatable Bond Count | 4 |
Exact Mass | 418.19804592 g/mol |
Monoisotopic Mass | 418.19804592 g/mol |
Topological Polar Surface Area | 62.4 Ų |
Heavy Atom Count | 30 |
Formal Charge | 0 |
Complexity | 579 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A TP 3654 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of TP 3654, including repackagers and relabelers. The FDA regulates TP 3654 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. TP 3654 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A TP 3654 supplier is an individual or a company that provides TP 3654 active pharmaceutical ingredient (API) or TP 3654 finished formulations upon request. The TP 3654 suppliers may include TP 3654 API manufacturers, exporters, distributors and traders.
TP 3654 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of TP 3654 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right TP 3654 GMP manufacturer or TP 3654 GMP API supplier for your needs.
A TP 3654 CoA (Certificate of Analysis) is a formal document that attests to TP 3654's compliance with TP 3654 specifications and serves as a tool for batch-level quality control.
TP 3654 CoA mostly includes findings from lab analyses of a specific batch. For each TP 3654 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
TP 3654 may be tested according to a variety of international standards, such as European Pharmacopoeia (TP 3654 EP), TP 3654 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (TP 3654 USP).
LOOKING FOR A SUPPLIER?